Se-Woong Oh
Seoul National University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Se-Woong Oh.
Physical Review Letters | 2002
J. Lee; Y. S. Lee; T. W. Noh; Se-Woong Oh; Jaejun Yu; Satoru Nakatsuji; H. Fukazawa; Y. Maeno
The optical conductivity spectra of the quasi-two-dimensional Ca2-xSrxRuO4 (0.0< or =x< or =2.0) system were investigated. In the Mott insulating state, two electron correlation-induced peaks were observed about 1.0 and 1.9 eV, which could be explained using the 3-orbital Hubbard model. The low frequency peak showed a shift toward higher frequency as temperature was lowered, indicating that electron-phonon interactions play an important role in the orbital arrangements. From the systematic analysis, it was suggested that the antiferro-orbital and the ferro-orbital ordering states could coexist.
Archives of Pharmacal Research | 2012
Se-Woong Oh; Jung Bok Lee; Bora Kim; Min-Kyoung Kim; Ki-Hoan Nam; Jong-Ryul Ha; Mickie Bhatia; Goo Taeg Oh; Dae-Yong Kim
Embryonic stem (ES) cells may be used as an alternative source of functionally intact cardiomyocytes for ischemic heart disease. Several natural and synthetic small molecules have been identified as useful tools for controlling and manipulating stem cell renewal and differentiation. Currently, there is an urgent requirement for novel small molecules that specifically induce differentiation of stem cells into cardiomyocytes. To identify compounds that promote cardiomyogenesis of stem cells, cell-based screening of a peptidomimetic small-molecule library was carried out. A series of β-turn peptidomimetic compounds, including CW209E, increased the expression of α-MHC promoter-driven enhanced green fluorescent protein (EGFP) and ratio of beating embryoid bodies (EBs) without inducing cytotoxicity in mouse embryonic stem cells. CW209E also increased the number of beating EBs in human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Thus, this chemical compound should be useful for elucidation of the molecular pathway of cardiogenesis and generation of cardiomyocytes ex vivo, which can be further applied for experimental or clinical cell therapy for ischemic heart diseases.
Smart Nano-Micro Materials and Devices | 2011
Se-Woong Oh; Hwi Kim; Junghyun Park; Seong-Woo Cho; Byoungho Lee
We investigate the synthesis of two-dimensional surface plasmon vortex power flows by a plasmonic vortex lens excited by oblique incident beams. It is shown that the plasmonic vortex lens can generate the off-centered vortex flows, the centers of which are determined by the incidence angle of the excitation beam. The theoretical analysis of the relationship between the off-center shift and the incidence angle is described. Furthermore it is shown that the illumination of two unparallel coherent incidence beams produces dual-vortex flows by the coherent superposition.
Archives of Pharmacal Research | 2001
Se-Woong Oh; Jong-Ryul Ha; Du-Jong Baek
Previous studies have demonstrated that CW252053, a quinazoline antifolate, exhibits potent inhibitory activity against thymidylate synthase (TS) as well as cytotoxic activity against tumor cell linesin vitro. In this study, we evaluated thein vivo antitumor efficacy of CW252053 in the mouse tumor model. Female B6D2F1 mice were injected with LY3.7.2C TK-/- (thymidine kinase deficient mouse lymphoma) cells into the gastrocnemius muscle. Then, CW252053 was administered twice daily by intraperitoneal injection for 10 days, and tumor growth was monitored daily by leg diameter measurement. All animals in the vehicle, 5-FU, and low dose (30 mg/kg) CW252053 treated groups died between days 12 and 23 because of the tumor burden. In contrast, dosing with 60 mg/kg of CW252053 produced a cure rate against tumor growth of 37.5% and a survival rate of 50%. Even more significantly, a higher dose of CW252053 (120 mg/kg) elicited both a 100% cure rate and a 100% survival rate at the termination of the study, confirming that this compound has very potentin vivo antitumor activity against tumor growth. During the experimental period of this study no signs of toxicity were observed even at the high CW252053 dosage rate of 120 mg/kg.
Physical Review Letters | 2012
S. Lee; Il-Min Lee; Junghyun Park; Se-Woong Oh; Woo Young Lee; Kyoung-Youm Kim; Byoungho Lee
Archive | 1998
Sung-Hwan Moon; Hea-Jin Choi; Su-Jin Lee; Jea-Uk Chung; Jong-Ryul Ha; Kyoung-June Lee; Se-Woong Oh; Kwang-Won Jeong
Biological & Pharmaceutical Bulletin | 2009
Se-Woong Oh; Dae-Hoon Kim; Jong-Ryul Ha; Dae-Yong Kim
Archive | 2002
Sung-Hwan Moon; Hea-Jin Choi; Su-Jin Lee; Jea-Uk Chung; Jong-Ryul Ha; Kwang-Won Jeong; Se-Woong Oh
Journal of Veterinary Medical Science | 1997
Se-Woong Oh; Chanhee Chae; Dong-Deuk Jang
Life Sciences | 2013
Se-Woong Oh; Bora Kim; Du-Min Go; Min-Kyoung Kim; Kyoung Eun Baek; Goo Taeg Oh; Dae-Yong Kim